These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 11817610)

  • 41. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
    Neidhart M; Gay RE; Gay S
    Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Mertens JC; Jüngel A; Brentano F; Maciejewska-Rodriguez H; Huber LC; Hemmatazad H; Wüest T; Knuth A; Gay RE; Michel BA; Gay S; Renner C; Bauer S
    Arthritis Rheum; 2010 May; 62(5):1224-35. PubMed ID: 20155839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis.
    Wernicke D; Seyfert C; Hinzmann B; Gromnica-Ihle E
    J Rheumatol; 1996 Apr; 23(4):590-5. PubMed ID: 8730110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell proliferation-related production of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin) by cultured human rheumatoid synovial fibroblasts.
    Hiraoka K; Sasaguri Y; Komiya S; Inoue A; Morimatsu M
    Biochem Int; 1992 Sep; 27(6):1083-91. PubMed ID: 1445377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion.
    Pap T; Aupperle KR; Gay S; Firestein GS; Gay RE
    Arthritis Rheum; 2001 Mar; 44(3):676-81. PubMed ID: 11263783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tenidap reduces the level of interleukin 1 receptors and collagenase expression in human arthritic synovial fibroblasts.
    Martel-Pelletier J; Mineau F; Tardif G; Fernandes JC; Ranger P; Loose L; Pelletier JP
    J Rheumatol; 1996 Jan; 23(1):24-31. PubMed ID: 8838504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation.
    Uitto VJ; Airola K; Vaalamo M; Johansson N; Putnins EE; Firth JD; Salonen J; López-Otín C; Saarialho-Kere U; Kähäri VM
    Am J Pathol; 1998 Jun; 152(6):1489-99. PubMed ID: 9626053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential adherence of osteoarthritis and rheumatoid arthritis synovial fibroblasts to cartilage and bone matrix proteins and its implication for osteoarthritis pathogenesis.
    Schedel J; Wenglén C; Distler O; Müller-Ladner U; Schölmerich J; Heinegård D; Krenn V
    Scand J Immunol; 2004 Nov; 60(5):514-23. PubMed ID: 15541045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.
    Neumann E; Judex M; Kullmann F; Grifka J; Robbins PD; Pap T; Gay RE; Evans CH; Gay S; Schölmerich J; Müller-Ladner U
    Gene Ther; 2002 Nov; 9(22):1508-19. PubMed ID: 12407423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction.
    Roy-Beaudry M; Martel-Pelletier J; Pelletier JP; M'Barek KN; Christgau S; Shipkolye F; Moldovan F
    Arthritis Rheum; 2003 Oct; 48(10):2855-64. PubMed ID: 14558091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes.
    Recklies AD; Baillargeon L; White C
    Arthritis Rheum; 1998 Jun; 41(6):997-1006. PubMed ID: 9627009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
    Pohlers D; Huber R; Ukena B; Kinne RW
    Arthritis Rheum; 2006 Mar; 54(3):788-94. PubMed ID: 16508943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL; Span PN; Sloetjes AW; Radstake TR; van Lieshout AW; Heuvel JJ; Sweep CG; van den Berg WB
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
    Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
    Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
    Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.